Marshall Vance Williams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marshall Vance Williams has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Maria Eugenia Ariza
Institute for Brain, Behavior, and Immunology (IBBI), The Ohio State University Wexner Center, Columbus, OH 43210, USA
7 shared publications - Irene Mena-Palomo
Institute for Brain, Behavior, and Immunology (IBBI), The Ohio State University Wexner Center, Columbus, OH 43210, USA
4 shared publications - Brandon Cox
Institute for Behavioral Medicine Research (IBMR), The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
3 shared publications Gautam N. Bijur
Department of Medical Microbiology, The Ohio State University, Columbus 43210, USA
3 shared publicationsMaria E. Ariza
Department of Medical Microbiology, Comprehensive Cancer Center, The Ohio State University, Columbus 43210, USA
3 shared publications- Brandon Cox
Institute for Brain, Behavior, and Immunology (IBBI), The Ohio State University Wexner Center, Columbus, OH 43210, USA
2 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by MDPI AG in Pathophysiology
- Vol. 33 (4) , 83
Signs and Symptoms Suggestive of Inflammatory Latent Herpesvirus Abortive Lytic Replication in U.S. Veterans with Chronic Multi-Symptom Illnesses
Background: Chronic multi-symptom illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objective: The collection of data to better characterize and assist in the development of a hypothesis that describes the pathophysiology of CMI. Design: This is an observational VA pilot study of a cohort of 40 U.S. Veterans with CMI. Methods: U.S. Veterans were initially referred to the Rehabilitation Medicine Service (RMS). From this pool of RMS patients, 36 males and four females diagnosed with CMI were selected. Data collected during this study included demographic data, medical history, psychological/cognitive information, and physical exam results. Lab tests were performed twice on the study subjects. Lab tests included serum 25(OH)D3 levels, calcium levels, and human serum IgM and IgG antibody levels to three herpetic virus dUTPase. Serum 25(OH)D3 levels were examined because active vitamin D has a role in immune system function, including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response. Herpesvirus dUTPases are proteins that are produced during viral DNA replication but are not structural components of virions. Human antibodies to dUTPase proteins were used as biomarkers for abortive lytic viral replication, a process that can stimulate an inflammatory immune process. Results: In our study subjects, the most common symptom was chronic pain (95%), the most common sign was hyperalgesia to pin prick (95%) and the most serious diagnoses were quadriparesis and neurocognitive decline in two study subjects. Conclusions: The clinical findings together with previous vitD and dUTPase serology studies suggest a possible association with low vitD levels, inflammatory elevated herpesvirus abortive lytic replication and CMI.
- 31 October 2026
- Published by MDPI AG in Pathophysiology
- Vol. 33 (4) , 83
Open AccessSigns and Symptoms Suggestive of Inflammatory Latent Herpesvirus Abortive Lytic Replication in U.S. Veterans with Chronic Multi-Symptom Illnesses
Background: Chronic multi-symptom illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objective: The collection of data to better characterize and assist in the development of a hypothesis that describes the pathophysiology of CMI. Design: This is an observational VA pilot study of a cohort of 40 U.S. Veterans with CMI. Methods: U.S. Veterans were initially referred to the Rehabilitation Medicine Service (RMS). From this pool of RMS patients, 36 males and four females diagnosed with CMI were selected. Data collected during this study included demographic data, medical history, psychological/cognitive information, and physical exam results. Lab tests were performed twice on the study subjects. Lab tests included serum 25(OH)D3 levels, calcium levels, and human serum IgM and IgG antibody levels to three herpetic virus dUTPase. Serum 25(OH)D3 levels were examined because active vitamin D has a role in immune system function, including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response. Herpesvirus dUTPases are proteins that are produced during viral DNA replication but are not structural components of virions. Human antibodies to dUTPase proteins were used as biomarkers for abortive lytic viral replication, a process that can stimulate an inflammatory immune process. Results: In our study subjects, the most common symptom was chronic pain (95%), the most common sign was hyperalgesia to pin prick (95%) and the most serious diagnoses were quadriparesis and neurocognitive decline in two study subjects. Conclusions: The clinical findings together with previous vitD and dUTPase serology studies suggest a possible association with low vitD levels, inflammatory elevated herpesvirus abortive lytic replication and CMI.
- Open Access
- 1 July 2026
- Published by MDPI AG in Preprints.org
Clinical Characteristics and Possible Pathophysiology of Chronic Multi-Symptom Illnesses in 40 U.S. Veterans
Background: Chronic Multi-symptom Illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objectives: 1. The collection of data to assist in the development of a hypothesis that describes the pathophysiology of CMI and related conditions including Gulf War Illness and Chronic Fatigue Syndrome. 2. Development of a better understanding of the consequences of this syndrome on the study subjects impaired level of functioning. Design: This is an observational VA Pilot study of a cohort of 40 US Veterans with Chronic Multi-symptom illness studied between 2019 and 2025. Methods: The study population was drawn from U.S. veterans who receive medical care from the W.G. Hefner VA Health Care System in Salisbury, N.C. U.S. veterans were initially referred to the Rehabilitation Medicine Service (RMS) for various diagnoses associated with chronic or persistent pain. From this pool of RMS patients, 36 males and 4 females who were diagnosed with Chronic Multi-symptom Illness and who met the study inclusion criteria were selected to participate in the study. Data collected from this study group included: demographic, medical history, and physical symptom information, psychological and cognitive evaluation and testing data, physical exam results, and serum lab test data. Lab tests were performed twice on the study subjects. Lab tests included serum active vitamin D precursor, 25(OH)D3, levels, calcium levels, and human IgM and IgG antibody levels to dUTPase enzymes from three latent herpetic viruses, Varicella Zoster virus (VZV), Human Herpes 6 virus (HH6V), and Epstein Barr virus (EBV). Serum active vitamin D precursor levels were examined because active vitamin D has a role in immune system function including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response to microbials including latent viruses. The herpesvirus dUTPases from EBV, HH6V, and VZV are proteins/enzymes in viral DNA replication but not structural components of the mature virion. In this pilot study, antibodies against these proteins were used as biomarkers for abortive lytic replication, a process that can stimulate an inflammatory immune process. This abortive lytic inflammatory process is hypothesized to be distinct from the inflammatory response associated with full lytic viral reactivation, which results in the production of complete virions. Results: Demographic Data – 75% of study subject men and 50 % of women served in combat. Comparison of our pilot study population to the general VA population revealed differences: US Marines made up 25% of our study population versus 9.9% in the general VA population, and African American/Black study subjects made up 30% or our study population verses 15% in the VA general population. Our study subjects had high service connected, disability/ compensation ratings: 55% or 22/40 had a rating of greater than or equal to 80%, and 22.5% or 9/40 had a rating of greater than or equal to 100%. Neurological findings in study subjects included hyperalgesia to pin prick over the skin, which was present in 95% of study subjects, tinnitus (ringing in the ears) in 82% of study subjects, decreased balance on heel to toe walking which was normal in only 28.9% of study subjects with their eyes open and in only 2.7% with eyes closed. This test could not be performed in 18.4% with eyes open and in 40.5% with their eyes closed. Two study subjects developed severe quadriparesis and idiopathic neurocognitive disorders later in the study after their initial interview, physical exam, cognitive testing and blood tests were performed. Serum Lab Tests: Vitamin D, 25(OH)D3 Levels: in Trial 1 – Deficient range 11/40 (27.5%), Insufficient range 17/40 (42.5%) in Trial 2 – Deficient range 8/36 (22.2%), Insufficient range 11/36 (30.6%) Note: Only two study subjects were deficient for both seasonally adjusted 25(OH)D3 levels checked in Trials 1&2 Human IgG antibody levels to Herpesvirus dUTPase proteins: Trial 1 serum test results for human IgG serum antibody levels to herpes virus dUTPase proteins were negative for all three viruses tested in 10/40 (25%) of study subjects and positive for all three viruses examined in 7/40 (17.5%) of study subjects. Trial 2 serum test results for human IgG antibody levels to herpes virus dUTPase enzymes were negative for all three viruses tested in only 1/36 (2.8%) study subjects. Human IgG dUTPase antibodies were positive for all three viruses in 17/36 (47%) study subjects. In Trial 1 – Human VZV IgG was Pos. (elevated) for VZV dUTPase in 11/40 (12.5%) of study subjects, In Trial 2 – Human VZV IgG was Pos. (elevated) for VZV dUTPases in 23/36 (64%) of study subjects.
- 1 July 2026
- Published by MDPI AG in Preprints.org
Open AccessClinical Characteristics and Possible Pathophysiology of Chronic Multi-Symptom Illnesses in 40 U.S. Veterans
Background: Chronic Multi-symptom Illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objectives: 1. The collection of data to assist in the development of a hypothesis that describes the pathophysiology of CMI and related conditions including Gulf War Illness and Chronic Fatigue Syndrome. 2. Development of a better understanding of the consequences of this syndrome on the study subjects impaired level of functioning. Design: This is an observational VA Pilot study of a cohort of 40 US Veterans with Chronic Multi-symptom illness studied between 2019 and 2025. Methods: The study population was drawn from U.S. veterans who receive medical care from the W.G. Hefner VA Health Care System in Salisbury, N.C. U.S. veterans were initially referred to the Rehabilitation Medicine Service (RMS) for various diagnoses associated with chronic or persistent pain. From this pool of RMS patients, 36 males and 4 females who were diagnosed with Chronic Multi-symptom Illness and who met the study inclusion criteria were selected to participate in the study. Data collected from this study group included: demographic, medical history, and physical symptom information, psychological and cognitive evaluation and testing data, physical exam results, and serum lab test data. Lab tests were performed twice on the study subjects. Lab tests included serum active vitamin D precursor, 25(OH)D3, levels, calcium levels, and human IgM and IgG antibody levels to dUTPase enzymes from three latent herpetic viruses, Varicella Zoster virus (VZV), Human Herpes 6 virus (HH6V), and Epstein Barr virus (EBV). Serum active vitamin D precursor levels were examined because active vitamin D has a role in immune system function including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response to microbials including latent viruses. The herpesvirus dUTPases from EBV, HH6V, and VZV are proteins/enzymes in viral DNA replication but not structural components of the mature virion. In this pilot study, antibodies against these proteins were used as biomarkers for abortive lytic replication, a process that can stimulate an inflammatory immune process. This abortive lytic inflammatory process is hypothesized to be distinct from the inflammatory response associated with full lytic viral reactivation, which results in the production of complete virions. Results: Demographic Data – 75% of study subject men and 50 % of women served in combat. Comparison of our pilot study population to the general VA population revealed differences: US Marines made up 25% of our study population versus 9.9% in the general VA population, and African American/Black study subjects made up 30% or our study population verses 15% in the VA general population. Our study subjects had high service connected, disability/ compensation ratings: 55% or 22/40 had a rating of greater than or equal to 80%, and 22.5% or 9/40 had a rating of greater than or equal to 100%. Neurological findings in study subjects included hyperalgesia to pin prick over the skin, which was present in 95% of study subjects, tinnitus (ringing in the ears) in 82% of study subjects, decreased balance on heel to toe walking which was normal in only 28.9% of study subjects with their eyes open and in only 2.7% with eyes closed. This test could not be performed in 18.4% with eyes open and in 40.5% with their eyes closed. Two study subjects developed severe quadriparesis and idiopathic neurocognitive disorders later in the study after their initial interview, physical exam, cognitive testing and blood tests were performed. Serum Lab Tests: Vitamin D, 25(OH)D3 Levels: in Trial 1 – Deficient range 11/40 (27.5%), Insufficient range 17/40 (42.5%) in Trial 2 – Deficient range 8/36 (22.2%), Insufficient range 11/36 (30.6%) Note: Only two study subjects were deficient for both seasonally adjusted 25(OH)D3 levels checked in Trials 1&2 Human IgG antibody levels to Herpesvirus dUTPase proteins: Trial 1 serum test results for human IgG serum antibody levels to herpes virus dUTPase proteins were negative for all three viruses tested in 10/40 (25%) of study subjects and positive for all three viruses examined in 7/40 (17.5%) of study subjects. Trial 2 serum test results for human IgG antibody levels to herpes virus dUTPase enzymes were negative for all three viruses tested in only 1/36 (2.8%) study subjects. Human IgG dUTPase antibodies were positive for all three viruses in 17/36 (47%) study subjects. In Trial 1 – Human VZV IgG was Pos. (elevated) for VZV dUTPase in 11/40 (12.5%) of study subjects, In Trial 2 – Human VZV IgG was Pos. (elevated) for VZV dUTPases in 23/36 (64%) of study subjects.
- Open Access
Does Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Represent a Poly-Herpesvirus Post-Virus Infectious Disease?
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem illness with unknown etiology. An estimated 17–24 million people representing approximately 1% of the population are afflicted worldwide. In over half of cases, ME/CFS onset is associated with acute “flu-like” symptoms, suggesting a role for viruses. However, no single virus has been identified as the only etiological agent. This may reflect the approach employed or more strongly the central dogma associated with herpesviruses replication, which states that a herpesvirus exists in two states, either lytic or latent. The purpose of this review is to address the role that abortive lytic replication may have in the pathogenesis of ME/CFS and other post-acute viral infections and also to raise awareness that these syndromes might be poly-herpesviruses mediated diseases.
Open AccessDoes Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Represent a Poly-Herpesvirus Post-Virus Infectious Disease?
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem illness with unknown etiology. An estimated 17–24 million people representing approximately 1% of the population are afflicted worldwide. In over half of cases, ME/CFS onset is associated with acute “flu-like” symptoms, suggesting a role for viruses. However, no single virus has been identified as the only etiological agent. This may reflect the approach employed or more strongly the central dogma associated with herpesviruses replication, which states that a herpesvirus exists in two states, either lytic or latent. The purpose of this review is to address the role that abortive lytic replication may have in the pathogenesis of ME/CFS and other post-acute viral infections and also to raise awareness that these syndromes might be poly-herpesviruses mediated diseases.
- Open Access
EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies
There is increasing evidence that put into question the classical dogma that the Epstein–Barr virus (EBV) exists in cells as either a lytic virus in which new progeny is produced or in a latent state in which no progeny is produced. Notably, a third state has now been described, known as the abortive-lytic phase, which is characterized by the expression of some immediate early (IE) and early (E) genes, but no new virus progeny is produced. While the function of these IE and E gene products is not well understood, several recent studies support the concept they may contribute to tumor promotion by altering the tumor microenvironment (TME). The mechanisms by which these viral gene products may contribute to tumorigenesis remain unclear; however, it has been proposed that some of them promote cellular growth, immune evasion, and/or inhibit apoptosis. One of these EBV early gene products is the deoxyuridine triphosphate nucleotidohydrolase (dUTPase) encoded by BLLF3, which not only contributes to the establishment of latency through the production of activin A and IL-21, but it may also alter the TME, thus promoting oncogenesis.
Open AccessEBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies
There is increasing evidence that put into question the classical dogma that the Epstein–Barr virus (EBV) exists in cells as either a lytic virus in which new progeny is produced or in a latent state in which no progeny is produced. Notably, a third state has now been described, known as the abortive-lytic phase, which is characterized by the expression of some immediate early (IE) and early (E) genes, but no new virus progeny is produced. While the function of these IE and E gene products is not well understood, several recent studies support the concept they may contribute to tumor promotion by altering the tumor microenvironment (TME). The mechanisms by which these viral gene products may contribute to tumorigenesis remain unclear; however, it has been proposed that some of them promote cellular growth, immune evasion, and/or inhibit apoptosis. One of these EBV early gene products is the deoxyuridine triphosphate nucleotidohydrolase (dUTPase) encoded by BLLF3, which not only contributes to the establishment of latency through the production of activin A and IL-21, but it may also alter the TME, thus promoting oncogenesis.
- Open Access
- 28 January 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (2) , 227
Viral dUTPases: Modulators of Innate Immunity
Most free-living organisms encode for a deoxyuridine triphosphate nucleotidohydrolase (dUTPase; EC 3.6.1.23). dUTPases represent a family of metalloenzymes that catalyze the hydrolysis of dUTP to dUMP and pyrophosphate, preventing dUTP from being incorporated into DNA by DNA polymerases, maintaining a low dUTP/dTTP pool ratio and providing a necessary precursor for dTTP biosynthesis. Thus, dUTPases are involved in maintaining genomic integrity by preventing the uracilation of DNA. Many DNA-containing viruses, which infect mammals also encode for a dUTPase. This review will summarize studies demonstrating that, in addition to their classical enzymatic activity, some dUTPases possess novel functions that modulate the host innate immune response.
- 28 January 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (2) , 227
Open AccessViral dUTPases: Modulators of Innate Immunity
Most free-living organisms encode for a deoxyuridine triphosphate nucleotidohydrolase (dUTPase; EC 3.6.1.23). dUTPases represent a family of metalloenzymes that catalyze the hydrolysis of dUTP to dUMP and pyrophosphate, preventing dUTP from being incorporated into DNA by DNA polymerases, maintaining a low dUTP/dTTP pool ratio and providing a necessary precursor for dTTP biosynthesis. Thus, dUTPases are involved in maintaining genomic integrity by preventing the uracilation of DNA. Many DNA-containing viruses, which infect mammals also encode for a dUTPase. This review will summarize studies demonstrating that, in addition to their classical enzymatic activity, some dUTPases possess novel functions that modulate the host innate immune response.
- Open Access
EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies
The Epstein-Barr virus (EBV), which is a ubiquitous γ-herpesvirus, establishes a latent infection in more than 90% of the global adult population. EBV-associated malignancies have increased by 14.6% over the last 20 years, and account for approximately 1.5% of all cancers worldwide and 1.8% of all cancer deaths. However, the potential involvement/contribution of lytic proteins to the pathophysiology of EBV-associated cancers is not well understood. We have previously demonstrated that the EBV-deoxyuridine triphosphate nucleotidohydrolase (dUTPase) modulates innate and adaptive immune responses by engaging the Toll-Like Receptor 2 (TLR2), which leads to the modulation of downstream genes involved in oncogenesis, chronic inflammation, and in effector T-cell function. Furthermore, examination of serum samples from diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia patients revealed the presence of increased levels of anti-dUTPase antibodies in both cohorts compared to controls with the highest levels (3.67-fold increase) observed in DLBCL female cases and the lowest (2.12-fold increase) in DLBCL males. Using computer-generated algorithms, dUTPase amino acid sequence alignments, and functional studies of BLLF3 mutants, we identified a putative amino acid motif involved with TLR2 interaction. These findings suggest that the EBV-dUTPase: TLR2 interaction is a potential molecular target that could be used for developing novel therapeutics (small molecules/vaccines).
Open AccessEBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies
The Epstein-Barr virus (EBV), which is a ubiquitous γ-herpesvirus, establishes a latent infection in more than 90% of the global adult population. EBV-associated malignancies have increased by 14.6% over the last 20 years, and account for approximately 1.5% of all cancers worldwide and 1.8% of all cancer deaths. However, the potential involvement/contribution of lytic proteins to the pathophysiology of EBV-associated cancers is not well understood. We have previously demonstrated that the EBV-deoxyuridine triphosphate nucleotidohydrolase (dUTPase) modulates innate and adaptive immune responses by engaging the Toll-Like Receptor 2 (TLR2), which leads to the modulation of downstream genes involved in oncogenesis, chronic inflammation, and in effector T-cell function. Furthermore, examination of serum samples from diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia patients revealed the presence of increased levels of anti-dUTPase antibodies in both cohorts compared to controls with the highest levels (3.67-fold increase) observed in DLBCL female cases and the lowest (2.12-fold increase) in DLBCL males. Using computer-generated algorithms, dUTPase amino acid sequence alignments, and functional studies of BLLF3 mutants, we identified a putative amino acid motif involved with TLR2 interaction. These findings suggest that the EBV-dUTPase: TLR2 interaction is a potential molecular target that could be used for developing novel therapeutics (small molecules/vaccines).
- Open Access
Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease
The human herpesviruses are ubiquitous viruses and have a prevalence of over 90% in the adult population. Following a primary infection they establish latency and can be reactivated over a person’s lifetime. While it is well accepted that human herpesviruses are implicated in numerous diseases ranging from dermatological and autoimmune disease to cancer, the role of lytic proteins in the pathophysiology of herpesvirus-associated diseases remains largely understudies. Only recently have we begun to appreciate the importance of lytic proteins produced during reactivation of the virus, in particular the deoxyuridine triphosphate nucleotidohydrolases (dUTPase), as key modulators of the host innate and adaptive immune responses. In this review, we provide evidence from animal and human studies of the Epstein–Barr virus as a prototype, supporting the notion that herpesviruses dUTPases are a family of proteins with unique immunoregulatory functions that can alter the inflammatory microenvironment and thus exacerbate the immune pathology of herpesvirus-related diseases including myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune diseases, and cancer.
Open AccessHerpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease
The human herpesviruses are ubiquitous viruses and have a prevalence of over 90% in the adult population. Following a primary infection they establish latency and can be reactivated over a person’s lifetime. While it is well accepted that human herpesviruses are implicated in numerous diseases ranging from dermatological and autoimmune disease to cancer, the role of lytic proteins in the pathophysiology of herpesvirus-associated diseases remains largely understudies. Only recently have we begun to appreciate the importance of lytic proteins produced during reactivation of the virus, in particular the deoxyuridine triphosphate nucleotidohydrolases (dUTPase), as key modulators of the host innate and adaptive immune responses. In this review, we provide evidence from animal and human studies of the Epstein–Barr virus as a prototype, supporting the notion that herpesviruses dUTPases are a family of proteins with unique immunoregulatory functions that can alter the inflammatory microenvironment and thus exacerbate the immune pathology of herpesvirus-related diseases including myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune diseases, and cancer.
- 13 September 2016
- Vol. 1 (1)
EBV-dUTPase Modulates Host Immune Responses Potentially Altering the Tumor Microenvironment in EBV-associated Malignancies
While the use of long-term antiretroviral therapy (ART) has improved immune function and reduced the incidence of some malignancies in human immunodeficiency virus (HIV-1) infected patients, this is not the case for non-Hodgkin’s lymphoma, an AIDS-defining cancer, and Hodgkin lymphoma, a non-AIDS defining cancer. Epstein-Barr virus (EBV) is an independent factor that adversely affects risk and/or survival among patients with Diffuse Large B cell Lymphoma (DLBCL) or classical Hodgkin lymphoma in immunocompetent patients as well as in HIV-1 infected individuals on ART. While cells infected with EBV in EBV-associated malignancies generally express one type of the latency programs, a small number of cells in these tumors are expressing EBV genes associated with lytic replication of the virus, which suggests that products from lytic or abortive-lytic replication may contribute to lymphomagenesis. However, the potential roles of these proteins in lymphomagenesis remain unclear. In this study we demonstrate that the EBV deoxyuridine triphosphate nucleotidohydrolase (dUTPase), an early protein produced during abortive/lytic EBV replication, is expressed in nasopharyngeal carcinoma (NPC) tumors in a mouse model of NPC, an EBV associated malignancy. Furthermore, screening of sera from 4 cohorts of patients diagnosed with AIDS, DLBCL, NPC and breast cancer (BC) by ELISA revealed an increase in IgG antibodies to the EBV-dUTPase in a subset of patients with AIDS, DLBCL and NPC relative to the controls. Finally, using an in vitro model of EBV infection we demonstrate that the EBV-dUTPase also inhibits T-cell function thus, allowing the proliferation of EBV immortalized B-cells. Altogether, our data support the premise that the EBV-dUTPase can modulate host immune responses and potentially alter the tumor microenvironment by promoting the survival/proliferation of immortalized B-cells, which may lead to lymphomagenesis.
- 13 September 2016
- Vol. 1 (1)
EBV-dUTPase Modulates Host Immune Responses Potentially Altering the Tumor Microenvironment in EBV-associated Malignancies
While the use of long-term antiretroviral therapy (ART) has improved immune function and reduced the incidence of some malignancies in human immunodeficiency virus (HIV-1) infected patients, this is not the case for non-Hodgkin’s lymphoma, an AIDS-defining cancer, and Hodgkin lymphoma, a non-AIDS defining cancer. Epstein-Barr virus (EBV) is an independent factor that adversely affects risk and/or survival among patients with Diffuse Large B cell Lymphoma (DLBCL) or classical Hodgkin lymphoma in immunocompetent patients as well as in HIV-1 infected individuals on ART. While cells infected with EBV in EBV-associated malignancies generally express one type of the latency programs, a small number of cells in these tumors are expressing EBV genes associated with lytic replication of the virus, which suggests that products from lytic or abortive-lytic replication may contribute to lymphomagenesis. However, the potential roles of these proteins in lymphomagenesis remain unclear. In this study we demonstrate that the EBV deoxyuridine triphosphate nucleotidohydrolase (dUTPase), an early protein produced during abortive/lytic EBV replication, is expressed in nasopharyngeal carcinoma (NPC) tumors in a mouse model of NPC, an EBV associated malignancy. Furthermore, screening of sera from 4 cohorts of patients diagnosed with AIDS, DLBCL, NPC and breast cancer (BC) by ELISA revealed an increase in IgG antibodies to the EBV-dUTPase in a subset of patients with AIDS, DLBCL and NPC relative to the controls. Finally, using an in vitro model of EBV infection we demonstrate that the EBV-dUTPase also inhibits T-cell function thus, allowing the proliferation of EBV immortalized B-cells. Altogether, our data support the premise that the EBV-dUTPase can modulate host immune responses and potentially alter the tumor microenvironment by promoting the survival/proliferation of immortalized B-cells, which may lead to lymphomagenesis.
- 26 March 2008
- Published by Wiley
- p. 287-318
Biological Activity of Mineral Fibers and Carbon Particulates: Implications for Nanoparticle Toxicity and the Role of Surface Chemistry
- 26 March 2008
- Published by Wiley
- p. 287-318
Biological Activity of Mineral Fibers and Carbon Particulates: Implications for Nanoparticle Toxicity and the Role of Surface Chemistry
- 24 March 1999
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 33 (2) , 144-152
Ascorbic acid-dehydroascorbate induces cell cycle arrest at G2/M DNA damage checkpoint during oxidative stress
Reactive oxygen species induce cellular damage and have been implicated as mediators for cellular signaling pathways. However, a linkage between the cellular redox status and cell cycle progression has not been demonstrated. We previously demonstrated, using the Chinese hamster ovary cell line AS52, that the cytotoxic and mutagenic effects of oxidative stress is prevented by ascorbic acid (AA), but only when cells are treated with AA prior to treatment with the stressor. To elucidate the mechanism(s) responsible for this effect, we determined the effect of AA on cell cycle progression during oxidative stress. Flow cytometric analyses demonstrated that treatment of AS52 cells with AA (50 μM), prior to treatment with a radical generating system (RGS), enhanced cell cycle arrest at the G2/M DNA damage checkpoint when compared to cells treated with RGS. AA had no effect on cell cycle progression in the absence of oxidative stress. Furthermore, under conditions that prevent the reduction of dehydroascorbate (DHA), the oxidized form of AA, cell cycle arrest was also induced at the G2/M DNA damage checkpoint. These observations demonstrate that during periods of oxidative stress, AA functions as an antioxidant and DHA enhances transient arrest at the G2/M checkpoint by delaying the activation of cyclin B‐cdc2. These results suggest the presence of a unique redox mechanism for the regulation of cell cycle progression and also demonstrate a novel mechanism by which AA protects cells from damage due to oxidative stress. Environ. Mol. Mutagen. 33:144–152, 1999
- 24 March 1999
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 33 (2) , 144-152
Ascorbic acid-dehydroascorbate induces cell cycle arrest at G2/M DNA damage checkpoint during oxidative stress
Reactive oxygen species induce cellular damage and have been implicated as mediators for cellular signaling pathways. However, a linkage between the cellular redox status and cell cycle progression has not been demonstrated. We previously demonstrated, using the Chinese hamster ovary cell line AS52, that the cytotoxic and mutagenic effects of oxidative stress is prevented by ascorbic acid (AA), but only when cells are treated with AA prior to treatment with the stressor. To elucidate the mechanism(s) responsible for this effect, we determined the effect of AA on cell cycle progression during oxidative stress. Flow cytometric analyses demonstrated that treatment of AS52 cells with AA (50 μM), prior to treatment with a radical generating system (RGS), enhanced cell cycle arrest at the G2/M DNA damage checkpoint when compared to cells treated with RGS. AA had no effect on cell cycle progression in the absence of oxidative stress. Furthermore, under conditions that prevent the reduction of dehydroascorbate (DHA), the oxidized form of AA, cell cycle arrest was also induced at the G2/M DNA damage checkpoint. These observations demonstrate that during periods of oxidative stress, AA functions as an antioxidant and DHA enhances transient arrest at the G2/M checkpoint by delaying the activation of cyclin B‐cdc2. These results suggest the presence of a unique redox mechanism for the regulation of cell cycle progression and also demonstrate a novel mechanism by which AA protects cells from damage due to oxidative stress. Environ. Mol. Mutagen. 33:144–152, 1999